| IP3R |
ci-IP3/PM(Caged IP3) (W. M. Zhang, Lin, & Sham, 2004) |
Heparin (Ehrlich, Kaftan, Bezprozvannaya, & Bezprozvanny, 1994), Xestospongin C (Gafni et al., 1997), 2-APB (Maruyama, Kanaji, Nakade, Kanno, & Mikoshiba, 1997) |
| RyR |
NAADP tetrasodium salt (Dammermann et al., 2009), Suramin (Hill, Kingston, & Sitsapesan, 2004) |
Dantrolene (Zhao, Li, Chen, Louis, & Fruen, 2001), JTV 519, Fumarate (Neumann, Diaz-Sylvester, Fleischer, & Copello, 2011), Ryanodine (C. P. Bianchi, 1997), Flecainide (Mehra, Imtiaz, van Helden, Knollmann, & Laver, 2014) |
| L-type Ca2+ channels |
(±)-Bay K 8644 (D. A. Greenberg, Cooper, & Carpenter, 1984), FPL 64176 (McDonough, Mori, & Bean, 2005) |
Amlodipine (Burges et al., 1987), (R)-(+)-Bay K 8644 (Mason, Gonye, Chester, & Herbette, 1989), Diltiazem (Kraus, Hering, Grabner, Ostler, & Striessnig, 1998), Isradipine (Hof, Scholtysik, Loutzenhiser, Vuorela, & Neumann, 1984), Verapamil (Lacinova, Ludwig, Bosse, Flockerzi, & Hofmann, 1995), Nifedipine (Stork & Cocks, 1994), Nimodipine (Izquierdo, 1990), Isradipine (Wada, Satoh, & Taira, 1985), Lercanidipine (S. Sonkusare, Srinivasan, Kaul, & Ramarao, 2005), Felodipine (Ljung, 1990) |
| T-type Ca2+ channels |
None known |
Mibefradil (Mehrke, Zong, Flockerzi, & Hofmann, 1994), ML 218 hydrochloride (Devergnas et al., 2016), Z 944 (Casillas-Espinosa et al., 2015), NNC 55–0369 (L. Huang et al., 2004), (2R/S)-6-PNG (Sekiguchi et al., 2018) |
| TRPM4 |
U73122 (Leitner et al., 2016) |
9-Phenanthrol (Simard, Salle, Rouet, & Guinamard, 2012) |
| TRPC1 |
None known |
GsMTx4 (C. L. Bowman, P. A. Gottlieb, T. M. Suchyna, Y. K. Murphy, & F. Sachs, 2007) |
| TRPC3 |
GSK 1702934A (de la Cruz et al., 2017) |
Pyr3 (Kiyonaka et al., 2009) |
| TRPC4 |
None known |
ML 204 (Miller et al., 2011) |
| TRPC6 |
GSK 1702934A (de la Cruz et al., 2017), Flufenamic acid (Guinamard, Simard, & Del Negro, 2013) |
SAR 7334 (Maier et al., 2015), GsMTx4 (Charles L. Bowman, Philip A. Gottlieb, Thomas M. Suchyna, Yolanda K. Murphy, & Frederick Sachs, 2007) |
| TRPV1 |
Anandamide (Guinamard et al., 2013), (E)Capsaicin (Holzer, 2008), MRS 1477 (Kaszas et al., 2012), NADA (S. M. Huang et al., 2002), 6’ Iodoresiniferatoxin (Appendino et al., 2003), Arvanil (Szallasi & Di Marzo, 2000),
OLDA (Chu et al., 2003), Rinvanil (Nam et al., 2015) |
A 425619 (El Kouhen et al., 2005), A 784168 (B. R. Bianchi et al., 2007), SB 366791 (Gunthorpe et al., 2004), SB 452533 (B. R. Bianchi et al., 2007), AMG 21629 (Tamayo et al., 2008), AMG 517 (Gavva et al., 2007), AMG 9810 (Doherty et al., 2005), BCTC (Pomonis et al., 2003), Capsazepine (Dickenson & Dray, 1991), 5’-Iodoresiniferatoxin (Wahl, Foged, Tullin, & Thomsen, 2001),
JNJ 17203212 (Swanson et al., 2005), L-R4W2 (Himmel, Kiss, Borvendeg, Gillen, & Illes, 2002)
α-Spinasterol (Trevisan et al., 2012) |
| TRPV3 |
Incensole Acetate(Moussaieff et al., 2008),
Farnesyl Pyrophosphate(Bang, Yoo, Yang, Cho, & Hwang, 2010),
Carvacrol, Eugenol, Thymol (H. Xu et al., 2006) |
17R-resolvin D1 (Bang, Yoo, Yang, Cho, & Hwang, 2012),
Ruthenium Red (Amann & Maggi, 1991) |
| TRPV4 |
GSK1016790A (Willette et al., 2008), RN 1747 (Vincent et al., 2009) |
RN 9893 (Wei et al., 2015), GSK 2193874 (Hong et al., 2018), HC 067047 (Everaerts et al., 2010), RN 1734 (Vincent et al., 2009),
Ruthenium Red (Amann & Maggi, 1991) |
| TRPA1 |
ASP 7663 (Vincent et al., 2009), JT010 (Takaya et al., 2015), Resveratrol (Vancauwenberghe et al., 2017), Allyl Isothiocyanate (Iwasaki, Tanabe, Kobata, & Watanabe, 2008),
Optovin (Kokel et al., 2013) |
A 967079 (J. Chen et al., 2011), AM 0902 (Schenkel et al., 2016), HC 030031 (Eid et al., 2008), AP 18 (Petrus et al., 2007), TCS 5861528 (Petrus et al., 2007) |
